By providing Hillgene's GMP-grade K562 feeder cells along with complete CMC documentation and FDA DMF support, this product can significantly reduce the workload of early-stage process development and validation.
Clients can directly reference the existing data and documentation, thereby minimizing redundant experiments, increasing submission efficiency, and reducing regulatory communication uncertainties. This ultimately accelerates IND submission and subsequent clinical development.
Learn more about our product here: Genetically Modified K562 Feeder Cell - Hillgene Biopharma Co., Ltd.